Michael E. Faerm

Insider Reports History

Entity
Individual
Location
C/O Theravance, Inc., 951 Gateway Boulevard, South San Francisco, CA
Signature
/s/ Michael E. Faerm
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael E. Faerm:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Viracta Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 500K May 14, 2024 Direct

Insider Reports Filed by Michael E. Faerm

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VIRX Viracta Therapeutics, Inc. May 14, 2024 1 $0 4 May 16, 2024 Chief Financial Officer
VIRX Viracta Therapeutics, Inc. May 13, 2024 0 $0 3 May 16, 2024 Chief Financial Officer